Sponsored Content
Sponsored by Incyte.
Long-Term Repigmentation Outcomes With OPZELURA® (Ruxolitinib) Cream 1.5% in Nonsegmental Vitiligo Regardless of Baseline Disease Activity
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
CVS Health is splitting in two, according to news reports
2
On Medicaid cuts, the Medicare Advantage market, commercial insurance and the future of U.S. health insurance: A conversation with Geisinger's Jeremy Gaskill
3
The CVS Health split. How separate will the two companies really be?
4
A Democratic Congress likely means more oversight for payers, not a Medicaid rollback
5